New research published in the European Journal of Pain is offering some of the first clinical trial insights into the efficacy of microdosing THC to treat chronic pain. The results of the small trial suggest minute doses of THC may confer clinically apparent reductions in pain sensation without…| New Atlas
An impressive new study led by scientists at Canada’s Western University has for the first time revealed one of the molecular mechanisms by which cannabidiol (CBD) directly blocks the negative psychiatric side effects generated by tetrahydrocannabinol (THC).| New Atlas
When participating in a psychedelic session becomes legal – in the form of psychedelic-assisted psychotherapy or a retreat – this doesn’t open up this experience to everyone equally. In the psychedelic industry, there remains the issue of access inequality. Legal, regulated psychedelic sessions are typically expensive. The cost of psychedelic therapy differs depending on the… The post Barriers to Healing: On Psychedelic Medicine and Access Inequality appeared first on Sam Woolfe.| Sam Woolfe
Catch up on the biggest cannabis and psychedelic news from last week, including a speed-rolling championship, celebrity dispensary burglary, major stock movers, and Texas’s historic $50M psychedelic research bill.| Cannabis & Tech Today
Reggie Harris speaks on psychedelics, spirituality, and reclaiming space for Black voices in the growing psychedelic movement.| Cannabis & Tech Today
Harm caused by repeated concussions, especially in the context of sports, has gained attention in both research and the media. A new study has found that psilocybin, the psychedelic ingredient in magic mushrooms, could be an effective treatment because of its brain-healing properties.| New Atlas
